Eric D. Shaff - Net Worth and Insider Trading
Eric D. Shaff Net Worth
The estimated net worth of Eric D. Shaff is at least $151,101 dollars as of 2024-12-28. Eric D. Shaff is the CEO and President of Seres Therapeutics Inc and owns about 170,389 shares of Seres Therapeutics Inc (MCRB) stock worth over $151,101. Details can be seen in Eric D. Shaff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric D. Shaff has not made any transactions after 2024-11-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric D. Shaff
Eric D. Shaff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric D. Shaff owns 2 companies in total, including Seres Therapeutics Inc (MCRB) , and Sigilon Therapeutics Inc (SGTX) .
Click here to see the complete history of Eric D. Shaff’s form 4 insider trades.
Insider Ownership Summary of Eric D. Shaff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2024-11-18 | CFO and EVP |
| SGTX | Sigilon Therapeutics Inc | 2020-12-03 | director |
Eric D. Shaff Latest Holdings Summary
Eric D. Shaff currently owns a total of 1 stock. Eric D. Shaff owns 170,389 shares of Seres Therapeutics Inc (MCRB) as of November 18, 2024, with a value of $151,101.
Latest Holdings of Eric D. Shaff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2024-11-18 | 170,389 | 0.89 | 151,101 |
Holding Weightings of Eric D. Shaff
Eric D. Shaff Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric D. Shaff has made a total of 6 transactions in Seres Therapeutics Inc (MCRB) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Seres Therapeutics Inc is the sale of 2,505 shares on November 18, 2024, which brought Eric D. Shaff around $1,353.
Insider Trading History of Eric D. Shaff
- 1
Eric D. Shaff Trading Performance
Eric D. Shaff Ownership Network
Eric D. Shaff Owned Company Details
What does Seres Therapeutics Inc do?
Who are the key executives at Seres Therapeutics Inc?
Eric D. Shaff is the CFO and EVP of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include Chief Scientific Officer Matthew R. Henn , See Remarks Thomas Desrosier , and See Remarks Moltke Lisa Von .
Seres Therapeutics Inc (MCRB) Insider Trades Summary
Over the past 18 months, Eric D. Shaff made 6 insider transaction in Seres Therapeutics Inc (MCRB) with a net sale of 36,307. Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 35,910 shares made by Teresa L. Young , a net sale of 15,855 shares made by Moltke Lisa Von , and a net sale of 14,948 shares made by Thomas Desrosier .
In summary, during the past 3 months, insiders sold 30,330 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 30,330 shares. During the past 18 months, 140,004 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 140,004 shares.
Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seres Therapeutics Inc Insider Transactions
Eric D. Shaff Mailing Address
Above is the net worth, insider trading, and ownership report for Eric D. Shaff. You might contact Eric D. Shaff via mailing address: C/o Seres Health, Inc., 161 First Street, Cambridge Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
